4-ipomeanol has been researched along with Carcinoma, Non-Small Cell Lung in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Christian, MC; Dearing, MP; Johnson, BE; Kasturi, VK; Kelley, MJ; Morton, TL; O'Neil, K; Piscitelli, SC; Russell, EK; Sladek, GG; Turner, GA | 1 |
1 trial(s) available for 4-ipomeanol and Carcinoma, Non-Small Cell Lung
Article | Year |
---|---|
Phase I study of a five-day dose schedule of 4-Ipomeanol in patients with non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Drug Administration Schedule; Female; Humans; Lung Diseases; Lung Neoplasms; Male; Middle Aged; Partial Thromboplastin Time; Terpenes | 1998 |